Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T15:52:04.575Z.
Calculation as of: 2026-10-06T15:52:04.575Z.
Quote observation: 2026-10-06T15:50:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d4371fef99df03934200e4dffcc755937dae78aec52c21603c02e47e686b1f66
PEG RATIO
N/A
Market Cap
$816.88M
PEG Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. (LXRX) | $786.94M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $789.07M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $796.23M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $774.83M | 12.13 | 8.33 | 8.33 | 8.33 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $799.38M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $776.26M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $804.23M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $803.93M | 1.14 | 0.85 | 0.47 | 0.33 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $816.88M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $767.14M | N/A | N/A | N/A | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
